Nighttime insomnia treatment and education for Alzheimer's disease: A randomized, controlled trial

被引:196
|
作者
McCurry, SM
Gibbons, LE
Logsdon, RG
Vitiello, MV
Teri, L
机构
[1] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98115 USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98115 USA
关键词
sleep; nocturnal disturbances; Alzheimer's disease; caregivers; actigraphy;
D O I
10.1111/j.1532-5415.2005.53252.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To evaluate whether a comprehensive sleep education program (Nighttime Insomnia Treatment and Education for Alzheimer's Disease (NITE-AD)) could improve sleep in dementia patients living at home with their family caregivers. DESIGN: A randomized, controlled trial. PARTICIPANTS: Thirty-six community-dwelling patients with Alzheimer's disease (AD) and their family caregivers. INTERVENTION: All participants received written materials describing age- and dementia-related changes in sleep and standard principles of good sleep hygiene. Caregivers in active treatment (n=17) received specific recommendations about setting up and implementing a sleep hygiene program for the dementia patient and training in behavior management skills. Patients in active treatment were also instructed to walk daily and increase daytime light exposure with the use of a light box. Control subjects (n=19) received general dementia education and caregiver support. MEASUREMENTS: Primary sleep outcomes were derived for patients and caregivers from 1 week of sleep-wake activity measured at baseline, posttest (2 months), and 6-month follow-up using an Actillume wrist-movement recorder. Secondary patient outcomes included the Epworth Sleepiness Scale, the Cornell Depression Scale, and the Revised Memory and Behavior Problem Checklist. Caregiver self-reports included the Pittsburgh Sleep Quality Index and the Center for Epidemiological Study of Depression Scale. RESULTS: Patients participating in NITE-AD showed significantly greater (P <.05) posttest reductions in number of nighttime awakenings, total time awake at night, and depression, and increases in weekly exercise days than control subjects. At 6-month follow-up, treatment gains were maintained, and additional significant improvements in duration of night awakenings emerged. When cognitive level was controlled, NITE-AD patients had lower longitudinal ratings of daytime sleepiness than controls. There was a trend for control subjects to spend more time in bed at 6 months than NITE-AD patients. CONCLUSION: This study provides the first evidence that patients with AD who are experiencing sleep problems can benefit from behavioral techniques (specifically, sleep hygiene education, daily walking, and increased light exposure) that are known to improve sleep in nondemented, institutionalized older adults.
引用
收藏
页码:793 / 802
页数:10
相关论文
共 50 条
  • [41] Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia
    Smitherman, Todd A.
    Walters, A. Brooke
    Davis, Rachel E.
    Ambrose, Carrie E.
    Roland, Malcolm
    Houle, Timothy T.
    Rains, Jeanetta C.
    HEADACHE, 2016, 56 (02): : 276 - 291
  • [42] Suvorexant for the treatment of insomnia in patients with Alzheimer's disease
    Hamuro, Atsushi
    Honda, Minoru
    Wakaura, Yuya
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 (02): : 207 - 208
  • [43] Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease
    Arnold, Steven E.
    Betensky, Rebecca A.
    ANNALS OF NEUROLOGY, 2018, 84 (02) : 168 - 175
  • [44] THE EFFECT OF ANTIHYPERTENSIVE TREATMENT ON THE PREVALENCE OF ORTHOSTATIC HYPOTENSION IN ALZHEIMER'S DISEASE: SECONDARY ANALYSES OF A RANDOMIZED CONTROLLED TRIAL (NILVAD TRIAL)
    De Heus, R.
    Lawlor, B.
    Rikkert, M. Olde
    Claassen, J.
    JOURNAL OF HYPERTENSION, 2018, 36 : E127 - E127
  • [45] Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial
    Zhang, Yulian
    Lin, Cuiru
    Zhang, Linlin
    Cui, Yuanwu
    Gu, Yun
    Guo, Jiakui
    Wu, Di
    Li, Qiang
    Song, Wanshan
    PLOS ONE, 2015, 10 (06):
  • [46] DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial - Reply
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Yaffe, K
    NEUROLOGY, 2004, 62 (06) : 1030 - 1030
  • [47] The impact of empowerment theory-based health education on Alzheimer's disease informal caregivers: a randomized controlled trial
    Liu, Xiaofeng
    Wang, Shurui
    Wei, Lirong
    Liu, Yun
    Bian, Jiping
    Wang, Shen
    Du, Xian
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [48] Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease - A randomized controlled trial
    Mulnard, RI
    Cotman, CW
    Kawas, C
    van Dyck, CH
    Sano, H
    Doody, R
    Koss, E
    Pfeiffer, E
    Jin, S
    Gamst, A
    Grundman, M
    Thomas, R
    Thal, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08): : 1007 - 1015
  • [49] Efficacy and safety of acupuncture treatment on primary insomnia: a randomized controlled trial
    Yin, Xuan
    Gou, Minghui
    Xu, Jian
    Dong, Bo
    Yin, Ping
    Masquelin, Fernand
    Wu, Junyi
    Lao, Lixing
    Xu, Shifen
    SLEEP MEDICINE, 2017, 37 : 193 - 200
  • [50] Cognitive Refocusing Treatment for Insomnia: A Randomized Controlled Trial in University Students
    Gellis, Les A.
    Arigo, Danielle
    Elliott, Jennifer C.
    BEHAVIOR THERAPY, 2013, 44 (01) : 100 - 110